Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial

Journal of the Neurological Sciences

Volumn 100, Issue 1-2, 1990, Pages 70-78

  Bresolin, N ^a   Doriguzzi, C ^b   Ponzetto, C ^b   Angelini, C ^c   Moroni, I ^a   Castelli, E ^a   Cossutta, E ^a   Binda, A ^g   Gallanti, A ^a   Gabellini, S ^d   Piccolo, G ^e   Martinuzzi, A ^c   Ciafaloni, E ^a   Arnaudo, E ^b   Liciardello, L ^f   Carenzi, A ^f   Scarlato, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f Zambon Group SpA   (Italy)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Mitochondrial myopathy; mtDNA deletion; Ubiquinone

Indexed keywords

UBIDECARENONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

BLOOD PLATELETS; CHROMOSOME DELETION; DNA, MITOCHONDRIAL; DOUBLE-BLIND METHOD; EXERTION; FEMALE; HUMAN; LACTATES; LACTIC ACID; MALE; MITOCHONDRIA; MITOCHONDRIA, MUSCLE; MUSCLES; MUSCULAR DISEASES; UBIQUINONE;

EID: 0025673969     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(90)90015-F     Document Type: Article

References (42)

1. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate
2. Ophthalmoplegia plus, a real nosological entity
3. Lumping or splitting?
4. Measurement of cytochromes in human skeletal muscle mitochondria isolated from fresh and frozen stored muscle specimens
5. Clinical and biochemical correlations in mitochondrial myopathies treated with Coenzyme Q10
6. Progressive cytochromec oxidase deficiency in a case of Kearns-Sayre syndrome: morphological and biochemical studies in muscle biopsies and autopsy tissues
7. Fatal infantile cytochromec oxidase deficiency: decrease of immunologically detectable enzyme in muscle
8. Isolation of a quinone from beef heart mitochondria
9. Chronic progressive external ophtalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with Coenzyme Q (CoQ)
10. Progressive ophthalmoplegia, glycogen storage and abnormal mitochondria
11. Mitochondrial myopathy
12. Ophthalmoplegia plus: classification of disorders associated with progressive external ophthalmoplegia
13. Response of genetically dystrophic mice to therapy with hexahydrocoenzyme Q4
14. Fluidizing effect of endogenous ubiquinone in bovine heart mitochondrial membranes
15. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
16. Aggregation and diffusion in the mitochondrial electron-transfer chain: role in electron flow and energy transfer
17. Effect of coenzyme Q on serum level of creatine phosphokinase in preclinical muscular dystrophy
18. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
19. Mitochondrial abnormalities in progressive external ophthalmoplegia
20. The Kearns-Sayre syndrome
21. Retinitis pigmentosa external ophthalmoplegia and complete heart block
22. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone
23. A relay model of lipid peroxidation in biological membranes
24. Coenzyme Q: a new group of quinones
25. Protein measurement with the Folin phenol reagent
26. Chronic progressive external ophthalmoplegia (CPEO): clinical, morphological and biochemical studies
27. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome
28. Transfer of exogenous coenzyme Q10 to inner membrane of heart mitochondria in rats
29. 31P NMR study
30. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome
31. Treatment of Kearns-Sayre syndrome with Q10
32. Rapid isolation of mitochondrial DNA by alkaline extraction
33. The clinical features of mitochondrial myopathy
34. Lateral diffusion of ubiquinone during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial membrane
35. Kearns-Sayre syndrome: a mitochondrial DNA deletion with coenzyme Q10 and succinate treatment response
36. Chronic external ophtalmoplegia and ptosis (CEOP): improved retinal cone function with ascorbate, phylloquinone, and coenzyme Q10
37. Detection of specific sequences among DNA fragments separated by gel electrophoresis
38. Reduced Coenzyme Q10 as an antioxidant of lipid peroxidation in bovine heart mitochondria
39. Genetic map of the mitochondrial DNAs
40. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological and biochemical characterization of a mitochondrial DNA disease
41. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus